iSTAR Medical presents procedural safety findings for MINIject S
Prof. Gus Gazzard delivers an oral presentation on a new delivery system and surgical technique for the supraciliary glaucoma implant at NOK 2026 in Gothenburg on 14 October.
See the latest news and media coverage for iSTAR Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology company developing minimally invasive glaucoma implants
istar-medical.comLast updated
Prof. Gus Gazzard delivers an oral presentation on a new delivery system and surgical technique for the supraciliary glaucoma implant at NOK 2026 in Gothenburg on 14 October.
Michel Vanbrabant will highlight positive MINIject trial outcomes in over 130 patients and plans for commercial launch and U.S. expansion.
Data confirm the MIGS device significantly reduces intraocular pressure and medication use in glaucoma patients 12 months after implant.
The round is led by LSP and Gimv, with Earlybird and BNP Paribas Fortis Private Equity, to develop and commercialise its MINIject glaucoma device in Europe and the US.
Five-year safety profile including corneal health confirmed and 38% IOP reduction sustained Over 5000 patients benefiting from limited commercial rollout of MINIject ® worldwide to-date...
- Alliance will provide opportunity for AbbVie to further expand its diverse eye care portfolio and provide additional treatment options for glaucoma patients - Collaboration...
(RTTNews) - AbbVie (ABBV) on Wednesday said it signed an alliance with iSTAR Medical SA, a Belgian medtech firm, to further develop and commercialize iSTAR's...
WAVRE, Belgium, Sept. 5, 2019 /PRNewswire/ -- iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today...
Track iSTAR Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.